Clinical Trial Update: Research Study Looking at How Well Semaglutide Works in People Suffering From Obesity and Knee Osteoarthritis [Phase 3]

View source ↗

Summary

Phase 3 study of semaglutide for obesity (and knee osteoarthritis) has completed and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Knee Osteoarthritis
• Obesity

Drugs mentioned

• WEGOVY (Semaglutide)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Obesity | Phase 3 | Status: COMPLETED | Results posted: 2024-08-13